Elisabeth Rosenthal
@RosenthalHealth
Sr. Contrib. Ed. @KFFHealthNews. MD. NYT. OpEd Writer. Bestselling Author. Prizes: Loeb, ONA, Elliott, etc. On list of "most influential people" in DC. Really?
ID:28258330
https://www.anamericansickness.com/ 02-04-2009 02:15:06
9,6K Tweets
21,3K Followers
1,6K Following
📺WATCH: Tahir Amin unpacks how Bristol Myers Squibb amassed dozens of additional patents on its top-selling drug Eliquis, then weaponized those patents to sue competitors and prevent them from entering the U.S. market.
It's official, as of today: I'm executive editor of KFF Health News.
Grateful to @drewaltman for his trust. Excited and humbled to lead an award-winning team of journalists. Check us out at kffhealthnews.org and californiahealthline.org.
Elisabeth Rosenthal THANK YOU for speaking out about this. It's ironic that attempts to make us feel part of a 'family' or 'team' only alienate us. What if the $$$$s spent on the hype were used to reduce ... oh, I dunno ... maybe drug costs?
Great news Daniel Chang. This project won a Polk Award last week and is still going strong....
If you are a self-insured company, THE FASTEST WAY TO CREATE CASH is to get all employees and covered persons to switch from Humira to Yusimry. The first costs you 80k per year. Yusimry from costplusdrugs.com/medications/yu…
Cost 7,200 per year. That's $72,800 PER EMPLOYEE PER YEAR.
You…